Activity value 72india Supplier,Last transaction date:
2026-02-23
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for umekir pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 29 transactions, with a transaction quantity of 61310 and a transaction weight of 0.
Product description
FORCE CP SILDENAFIL 50 MG
Expand
+View All
Products
Total 15
ProductsTransactionsPerDetail
tablet 375%>
aceclo 125%>
aceclofenac 125%>
anta 125%>
anzol 125%>
+View All
Hscode rank
Total 0
HSCode NameTransactionsPerDetail
HS 300490994100%>
Trading Area
Total 4
AreaTransactionsPerDetail
france4372.88%>
fiji1118.64%>
the republic of congo46.78%>
the democratic republic of the congo11.69%>
Port statistics
Total 5
Port NameTransactionsPerDetail
jawaharlal nehru (nhava sheva)2135.59%>
bombay air1728.81%>
mumbai (ex bombay)1423.73%>
sahar air cargo acc inbom446.78%>
bombay air cargo23.39%>
umekir pharma is india Supplier,
and primarily engages in the import and export business of products such as tablet,aceclo,aceclofenac.
According to the 52wmb.com global trade database, as of 2026-02-23, the company has completed 59 international trades,
with its main trading regions covering france,fiji,the republic of congo etc.
The core products include HS30049099 etc,
often transported via jawaharlal nehru (nhava sheva),port bombay air, port mumbai (ex bombay) etc,
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on umekir pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.